Palisade Bio
PALI
8 hedge funds and large institutions have $56.2M invested in Palisade Bio in 2014 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
14% more funds holding
Funds holding: 7 → 8 (+1)
0% more ownership
Funds ownership: 0% → 0% (+0%)
2% less capital invested
Capital invested by funds: $57.1M → $56.2M (-$871K)
49% less call options, than puts
Call options by funds: $351K | Put options by funds: $691K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
|
-$183K |
| 2 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
-$66K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$34K |
| 4 |
Jane Street
New York
|
-$33K |
| 5 |
M&T Bank
Buffalo,
New York
|
-$33K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HF
76
Hoxton Financial
Shepherdstown,
West Virginia
| $1K | – | – | – |
|
77
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $135 | – | – | – |
|
78
BNP Paribas Financial Markets
Paris,
France
| – | -$13.6K | – | – |
|
79
Dimensional Fund Advisors
Austin,
Texas
| – | -$29K | – | – |
|
|
80
Jane Street
New York
| – | -$33K | – | – |
|
|
MLICM
81
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$183K | – | – |
|
|
82
M&T Bank
Buffalo,
New York
| – | -$33K | – | – |
|
|
TRCT
83
Tower Research Capital (TRC)
New York
| – | -$34K | – | – |
|
|
UCFA
84
United Capital Financial Advisors
Irving,
Texas
| – | -$66K | – | – |
|
PALI Hedge Fund Activity: Q4 2014 in Review
8 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q4 2014, worth a combined $56.2M — down 1.5% from $57.1M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new PALI positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $3.29M. The largest seller was Metropolitan Life Insurance Company (MetLife), cutting an estimated $183K.
- 8 institutional investors held Palisade Bio (PALI) as of Q4 2014, up from 7 in Q3 2014.
- Funds reported $56.2M of Palisade Bio stock for Q4 2014, down 1.5% quarter-over-quarter.
- 1 fund opened new Palisade Bio positions in Q4 2014 and 0 closed out, a net change of +1 holder.
- The largest Palisade Bio buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $3.29M added.
- The largest Palisade Bio seller in Q4 2014 was Metropolitan Life Insurance Company (MetLife), an estimated $183K sold.
Based on aggregated 13F filings for Q4 2014.